BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32608010)

  • 1. Demographic characteristics, thromboembolism risk, and treatment patterns for patients with cold agglutinin disease in Japan.
    Kamesaki T; Nishimura JI; Wada H; Yu E; Tsao E; Morales J; Kanakura Y
    Int J Hematol; 2020 Sep; 112(3):307-315. PubMed ID: 32608010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence, thromboembolic risk, and mortality in Danish patients with cold agglutinin disease.
    Bylsma LC; Gulbech Ording A; Rosenthal A; Öztürk B; Fryzek JP; Arias JM; Röth A; Berentsen S
    Blood Adv; 2019 Oct; 3(20):2980-2985. PubMed ID: 31648316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased risk of thrombotic events in cold agglutinin disease: A 10-year retrospective analysis.
    Broome CM; Cunningham JM; Mullins M; Jiang X; Bylsma LC; Fryzek JP; Rosenthal A
    Res Pract Thromb Haemost; 2020 May; 4(4):628-635. PubMed ID: 32548562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthcare resource utilization among commercially insured patients with cold agglutinin disease in the United States.
    Su J; Bylsma LC; Jiang X; Morales Arias J; Jain N; Nordyke RJ
    J Med Econ; 2020 Aug; 23(8):902-907. PubMed ID: 32362156
    [No Abstract]   [Full Text] [Related]  

  • 5. Thromboembolic complications in autoimmune hemolytic anemia: Retrospective study.
    Schär DT; Daskalakis M; Mansouri B; Rovo A; Zeerleder S
    Eur J Haematol; 2022 Jan; 108(1):45-51. PubMed ID: 34551149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthcare resource utilization among patients with cold agglutinin disease in Denmark.
    Vágó EK; Nicholson G; Horváth-Puhó E; Hooda N; Fryzek JP; Su J
    Curr Med Res Opin; 2021 Oct; 37(10):1829-1835. PubMed ID: 34308723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of cancer-associated thromboembolism in Japanese gastric and colorectal cancer patients receiving chemotherapy: a single-institutional retrospective cohort analysis (Sapporo CAT study).
    Aonuma AO; Nakamura M; Sakamaki K; Murai T; Matsuda C; Itaya K; Sone T; Yagisawa M; Koike Y; Endo A; Tsukuda Y; Ono Y; Nagasaka A; Nishikawa S; Yamanaka T; Sakamoto N
    BMJ Open; 2019 Aug; 9(8):e028563. PubMed ID: 31439602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement-mediated hemolysis persists year round in patients with cold agglutinin disease.
    Röth A; Fryzek J; Jiang X; Reichert H; Patel P; Su J; Morales Arias J; Broome CM
    Transfusion; 2022 Jan; 62(1):51-59. PubMed ID: 34813663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medically-attended anxiety and depression is increased among newly diagnosed patients with cold agglutinin disease: Analysis of an integrated claim-clinical cohort in the United States.
    Broome CM; Hooda N; Su J; Jiang X; Nicholson G; Frankenfeld CL; Iglesias-Rodriguez M; Fryzek J; Patel P
    PLoS One; 2022; 17(12):e0276617. PubMed ID: 36520848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboembolisms in Advanced Pancreatic Cancer: A Retrospective Analysis of 475 Patients.
    Ishigaki K; Nakai Y; Isayama H; Saito K; Hamada T; Takahara N; Mizuno S; Mohri D; Kogure H; Matsubara S; Yamamoto N; Tada M; Koike K
    Pancreas; 2017 Sep; 46(8):1069-1075. PubMed ID: 28787333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cold agglutinin-mediated autoimmune hemolytic anemia.
    Berentsen S; Randen U; Tjønnfjord GE
    Hematol Oncol Clin North Am; 2015 Jun; 29(3):455-71. PubMed ID: 26043385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of thromboembolism in patients with idiopathic autoimmune hemolytic disease and antiphospholipid antibodies: results from a prospective, case-control study.
    Bongarzoni V; Annino L; Roveda A; Amendolea MA; Tirindelli MC; Avvisati G
    Haematologica; 2005 May; 90(5):711-3. PubMed ID: 15929203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group.
    Starling N; Rao S; Cunningham D; Iveson T; Nicolson M; Coxon F; Middleton G; Daniel F; Oates J; Norman AR
    J Clin Oncol; 2009 Aug; 27(23):3786-93. PubMed ID: 19398575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement Activation and Inhibition in Autoimmune Hemolytic Anemia: Focus on Cold Agglutinin Disease.
    Berentsen S
    Semin Hematol; 2018 Jul; 55(3):141-149. PubMed ID: 30032751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary chronic cold agglutinin disease: a population based clinical study of 86 patients.
    Berentsen S; Ulvestad E; Langholm R; Beiske K; Hjorth-Hansen H; Ghanima W; Sørbø JH; Tjønnfjord GE
    Haematologica; 2006 Apr; 91(4):460-6. PubMed ID: 16585012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboembolic Risk of Imaging-Confirmed Coronary Artery Disease Without Myocardial Infarction in Patients With Nonvalvular Atrial Fibrillation.
    Cho MS; Lee K; Choi KJ; Lee JB; Do U; Kim YN; Kim J; Nam GB; Kim YH
    Am J Cardiol; 2019 Apr; 123(8):1287-1292. PubMed ID: 30709601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between Coombs-positive autoimmune hemolytic anemia and development of malignant tumors: a retrospective study].
    Hirose T; Tokunaga H; Shimizu-Koresawa R; Yamada S; Kondo T; Suetsugu Y; Nakanishi H; Kanda E; Kondo E; Wada H
    Rinsho Ketsueki; 2019; 60(10):1418-1424. PubMed ID: 31695001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world, retrospective study evaluating thromboembolic events, associated risk factors, and health-care resource utilization in Japanese patients with polycythemia vera.
    Komatsu N; Jun G; Yonezu T; Ohashi Y
    Int J Hematol; 2020 Aug; 112(2):176-184. PubMed ID: 32394272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of thromboembolism following acute intracerebral hemorrhage.
    Goldstein JN; Fazen LE; Wendell L; Chang Y; Rost NS; Snider R; Schwab K; Chanderraj R; Kabrhel C; Kinnecom C; Fitzmaurice E; Smith EE; Greenberg SM; Rosand J
    Neurocrit Care; 2009; 10(1):28-34. PubMed ID: 18810667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sutimlimab for treatment of cold agglutinin disease: why, how and for whom?
    Berentsen S; Barcellini W; D'Sa S; Jilma B
    Immunotherapy; 2022 Oct; 14(15):1191-1204. PubMed ID: 35946351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.